There s. to them THAT S WHY THERE S MORE TO GAMUNEX-C

Size: px
Start display at page:

Download "There s. to them THAT S WHY THERE S MORE TO GAMUNEX-C"

Transcription

1 There s more to them THAT S WHY THERE S MORE TO GAMUNEX-C YOUR GUIDE TO CARING FOR SOMEONE WITH CIDP* *Chroic iflammatory demyeliatig polyeuropathy.

2 TABLE OF CONTENTS What is CIDP?... 4 What causes CIDP?... 5 Why is CIDP sometimes misdiagosed?... 6, 7 What to expect with CIDP... 8 What are the goals of CIDP treatmet?... 9 What is GAMUNEX-C? How does GAMUNEX-C work? Is GAMUNEX-C right for CIDP patiets who may have other coditios? How effective is GAMUNEX-C? How is GAMUNEX-C admiistered? Helpful tips for a better ifusio experiece Are there ay side effects with GAMUNEX-C?...16 CIDP Symptom Tracker Gamuex Coexios: Sigle poit of cotact Gamuex Coexios: Savigs ad support Helpful resources...20 CIDP resources ad support Importat Safety Iformatio

3 GET IN THE KNOW ABOUT CIDP Someoe you care for has bee diagosed with chroic iflammatory demyeliatig polyeuropathy (CIDP). The cause of this rare ad progressive autoimmue disease a disease i which the body s immue system attacks healthy cells is uclear. 1 What is clear is that CIDP is treatable ad its symptoms ca be reversed if caught early eough. 2,3 That s why a eurologist has recommeded treatmet with GAMUNEX-C to help improve the CIDP symptoms of the perso you care for. This booklet is desiged to help you help the perso you care for lear about CIDP, treatmet with GAMUNEX-C, ad how Gamuex Coexios ca provide support throughout his/her treatmet jourey. If you have ay questios about this iformatio or about GAMUNEX-C, be sure to talk with a eurologist or a certified urse at Gamuex Coexios. SPEAK WITH A CERTIFIED NURSE AT GAMUNEX CONNEXIONS. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) 3

4 What is CIDP? A rare autoimmue disease CIDP is a rare ad progressive autoimmue disease i which the body s ow immue system attacks the erves i the arms ad legs. The most commo symptoms of CIDP are 1,4 : Weakess Numbess Tiglig i legs, arms, figers, ad hads Other symptoms iclude fatigue, pai, balace issues, ad impairmet of ability to walk. 1,4 The symptoms of CIDP usually occur o both sides of the body at the same time. But sometimes oly oe side is ivolved. These symptoms ca be mild, moderate, or severe ad ca chage i severity over time. 4,5 You might hear the perso you care for describe THEiR symptoms as... I feel as if there is a lightig storm takig place i my arms ad legs. 4

5 WHAT CAUSES CIDP? Damage to the coverig of the erves Experts are t quite sure why people get CIDP, so there is o kow cause for this disorder. However, they do agree that CIDP begis whe the body s ow immue system attacks ad iflames (swells, irritates) healthy erves ad surroudig cells. This iflammatio ca lead to the damage of myeli, which leads to slowig of erve sigals. 1,2,6 Whe myeli, the protective coverig of the peripheral erves (erves located outside of the brai ad spial cord), is damaged by the body s ow immue system, messages from the brai to various parts of the body get disrupted. 2,6,7 autoatibodies damaged myeli sheath plasma cell macrophage This disruptio of messages ca cause weakess ad gradual loss of sesatios ad reflexes. Over time, the damage to myeli ad peripheral erves ca lead to disability i the truk, arms, ad legs, ad ca have a egative impact o quality of life. 6 Have ay questios? get aswers from a certified urse at Gamuex Coexios. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) 5

6 WHY IS CIDP SOMETIMES MISDIAGNOSED? CIDP ca be hard to diagose It ca be a challege to diagose CIDP because its symptoms resemble those of other ervous system disorders. Because of the similarities with symptoms of other disorders, it ca take up to several moths to obtai a accurate diagosis of CIDP. 1,4,6,8-11 Muscles Legs ad feet Arms ad hads Patter of ivolvemet Progressio of disease CIDP Loss of muscle toe Weak ad ucoordiated with umbess ad tiglig Weak ad ucoordiated with umbess ad tiglig Typically ivolves 2 or more limbs o both sides of the body at the same time Symptom progressio varies from moths to years. Symptoms get worse over time MS Stiffess Weak ad ucoordiated, heavy, ad stiff with umbess ad tiglig Weak ad ucoordiated with umbess ad tiglig Typically ivolves 1 or more limbs o oe side of the body Symptom progressio varies from moths to years. Symptoms get worse over time ALS Stiffess or loss of muscle toe Weak, stiff, or heavy (o umbess or tiglig) Weak (o umbess or tiglig) Symptoms may start i the togue, throat, arms, legs, or breathig muscles Reletless symptom progressio with permaet loss of fuctios GBS May be achy or paiful Weak ad ucoordiated with umbess ad tiglig Weak ad ucoordiated with umbess ad tiglig sesatios i hads Typically starts i the legs ad ca spread to the upper body Symptoms are more sudde (days to weeks). Brief progressio of symptoms followed by slow recovery over moths or years MS = multiple sclerosis; ALS = amyotrophic lateral sclerosis; GBS = Guillai-Barré sydrome. 6

7 CIDP VS MS, ALS, AND GBS CIDP vs MS While CIDP shares some symptoms with MS, certai symptoms such as problems with cocetratio, visio, speech, ad the bladder are ofte see with MS, but ot with CIDP. 8 CIDP vs ALS Although some CIDP symptoms may appear similar to those of ALS, ALS does ot cause umbess, tiglig, or uusual sesatios. Also, ALS commoly causes symptoms such as muscle twitchig, weight loss, ad muscle wastig, as well as problems speakig, breathig, ad swallowig. 9 CIDP vs GBS GBS symptoms quickly develop over days to weeks, ad the slowly get better agai. CIDP symptoms progress gradually over 2 to 6 moths or more. 6 HAVE ANY QUESTIONS ABOUT CIDP? TALK WITH A CERTIFIED NURSE AT GAMUNEX CONNEXIONS. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) 7

8 WHAT TO EXPECT WITH CIDP CIDP gets progressively worse without treatmet Iitially, people with CIDP may simply be aware that it takes more effort to do the thigs they used to do. Over several moths the symptoms may progress to the poit that the perso you care for may o loger be able to do simple daily activities. 6 Without treatmet, permaet erve damage that leads to disability ca occur. Whe this happes, quality of life suffers ad everyday tasks like climbig stairs, walkig, reachig for items, ad liftig objects overhead ca become difficult to perform. 3,6 It is critical to treat CIDP immediately because permaet erve damage caot be reversed 8

9 WHAT are THE GOALs OF CIDP TREATMENT? Reduce symptoms ad preserve physical idepedece The goals of treatmet for CIDP are to reduce symptoms (weakess, sesory loss, imbalace, ad pai), improve physical-fuctioal ability (coordiatio, stregth, ad balace), ad reach ad maitai log-term remissio (disappearace of symptoms). 12 Helpful tips for the maagemet of CIDP CIDP must be treated to prevet disability ad to potetially reduce the eed for wheelchairs, walkers, ad other assistive devices Timely ad close follow-up care is ecessary to adjust treatmet Regular cosultatios with a eurologist are recommeded Physical therapy ad a active lifestyle are ecouraged Joi CIDP support groups for up-to-date sharig of iformatio with other patiets ad their families TO LEARN MORE ABOUT WHAT TO EXPECT WITH CIDP, SPEAK WITH A CERTIFIED NURSE AT GAMUNEX CONNEXIONS. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) 9

10 WHAT IS GAMUNEX-C? GAMUNEX-C is the first FDA-approved IVIG treatmet for CIDP GAMUNEX-C is a itraveous immue globuli (IVIG) therapy for the treatmet of adult patiets with CIDP. Immue globulis are healthy atibodies that come from doated huma plasma. Plasma is the liquid part of the blood ad cotais atibodies eeded to keep you healthy. 13,14 This doated huma plasma is collected i licesed US plasma door ceters that are strictly moitored by Grifols ad the FDA. Each plasma door ad plasma doatio is carefully screeed to help make sure that the fial product is safe for use. It takes about 130 plasma doatios to treat 1 patiet for 1 year. 14 Because GAMUNEX-C is made from huma blood, it may carry a risk of trasmittig ifectious agets such as viruses, the variat Creutzfeldt-Jakob disease (vcjd) aget, ad, theoretically, the Creutzfeldt-Jakob disease (CJD) aget. 10

11 HOW DOES GAMUNEX-C WORK? Everyoe has protei molecules i their body called atibodies that are part of the body s immue system. These atibodies idetify ad kill bacteria, fugi, parasites, viruses, ad other foreig ivaders that may harm the body. 13 A additioal role of the immue system is to heal the body after ijury. Treatmet with GAMUNEX-C 3,6 1. Provides healthy atibodies to block the immue ad iflammatory processes 2. Protects erves ad their protective myeli coverig Atibodies Myeli Nerve The way i which GAMUNEX-C works i treatmet of people with CIDP is ot completely uderstood

12 IS GAMUNEX-C RIGHT FOR CIDP PATIENTS WHO MAY HAVE OTHER CONDITIONS? GAMUNEX-C has bee approved for the treatmet of CIDP eve i patiets who may have other coditios such as diabetes, heart complicatios, ad kidey problems. 16 Because of this, treatmet with GAMUNEX-C may meet the eeds of a lot of differet people with CIDP. A optio for CIDP patiets who have diabetes Immue globuli (IG) therapies cotaiig sugar stabilizers are more likely to iterfere with diabetes treatmets ad cause kidey-related side effects. GAMUNEX-C cotais o sugar ad o preservatives. 16 A optio for CIDP patiets who have heart coditios Icreased salt cotet may icrease the risk of swellig, fluid overload, ad cogestive heart failure. GAMUNEX-C cotais oly trace amouts of salt. 16 I a exteded phase of a cliical study, people give Gamuex-C who achieved sustaied remissio did ot drop out 17 I a cliical study with CIDP patiets who got GAMUNEX-C itraveously, the most commo side effects were pai i the regio of the head or eck; raised body temperature or fever; abormally high blood pressure; feeligs of coldess accompaied by shiverig; a oticeable chage i the texture or color of your ski such as your ski becomig scaly, bumpy, itchy, or otherwise irritated; a sesatio of uease ad discomfort i the upper stomach; joit pai; ad abormal physical weakess or lack of eergy. The most serious side effects i cliical studies were a blood clot to the lug (pulmoary embolism) i 1 patiet with a history of this coditio (i CIDP). 12

13 HOW EFFECTIVE IS GAMUNEX-C? The effectiveess of GAMUNEX-C was established i a ladmark cliical trial kow as the ICE* study. This study, the logest reported trial of ay CIDP treatmet, showed that GAMUNEX-C was effective for the short-term ad log-term treatmet of CIDP. 17 GAMUNEX-C i the ICE study showed 17 : Sigificat improvemet i disability scores through 24 weeks Improved grip stregth i both hads 87% of patiets were relapse-free at 48 weeks HAVE QUESTIONS ABOUT TREATMENT WITH GAMUNEX-C? TALK WITH A CERTIFIED NURSE AT GAMUNEX CONNEXIONS. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) Do ot take GAMUNEX-C if you have a allergy to immue globuli. Tell your doctor if you have had a serious reactio to other medicies that cotai huma immue globuli. Also tell your doctor if you have immuoglobuli A (IgA) deficiecy. If you have a serious reactio while takig GAMUNEX-C, stop takig it immediately ad tell your doctor. *ICE = 10% caprylate-chromatography purified immue globuli itraveous (IGIV-C) CIDP efficacy. 13

14 HOW IS GAMUNEX-C ADMINISTERED? GAMUNEX-C is admiistered itraveously (IV) through a vei, typically i the arm. It ca be take at a ifusio ceter, hospital, or i the coveiece of the home. Preparig for itraveous therapy The first ifusio of GAMUNEX-C for the perso you care for may occur over the course of 2 days or loger. Durig this time, a healthcare professioal will be closely moitorig his/her health status to esure that he/she is toleratig GAMUNEX-C After the first ifusio, admiistratio of GAMUNEX-C usually takes 2 to 4 hours from start to fiish The perso you care for should cosider brigig somethig to occupy his/her time like a game, book, or tablet A eurologist or ifusio urse may ask you to help the perso you care for keep track of how he/she is feelig so that the best treatmet schedule ca be determied The umber of ifusios that the perso you care for receives will be determied by his/her eurologist, depedig o idividual eed TO SEE A VIDEO ON HOW GAMUNEX-C IS ADMINISTERED, VISIT GAMUNEX-C.COM. 14

15 HELPFUL TIPS FOR A BETTER INFUSION EXPERIENCE Preparig for ifusio Be sure to iform the eurologist or urse of ay medicatios the perso you care for is takig Make sure the perso you care for driks a lot of fluids ad icreases fluid itake 24 hours before ifusio Additioally, the eurologist or urse might tell the perso you care for to take over-the-couter medicatios 30 miutes before the ifusio starts to help prevet possible headache, rash, or itchig to avoid discomfort Durig ifusio Be sure the perso you care for dresses i comfortable clothes Make sure all ecessary forms have bee filled out ad completed Tell the eurologist or urse if the perso you care for is feelig discomfort After ifusio Note ay improvemets or worseig of symptoms (o matter how big or how small) Share your observatios with the eurologist TO HAVE A BETTER INFUSION EXPERIENCE, SPEAK WITH A CERTIFIED NURSE AT GAMUNEX CONNEXIONS. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) 15

16 ARE THERE ANY SIDE EFFECTS WITH GAMUNEX-C? All medicies have risks ad side effects. Ad, treatmets for CIDP are ot a exceptio to this. Be sure the perso you care for speaks with a eurologist about these commo side effects of GAMUNEX-C. The most commo side effects for patiets with CIDP takig GAMUNEX-C were 15 : Pai i the regio of the head or eck Raised body temperature or fever Abormally high blood pressure Feeligs of coldess ad/or shiverig Noticeable chage i the texture or color of the ski such as the ski becomig scaly, bumpy, itchy, or otherwise irritated Sesatio of uease ad discomfort i the upper stomach Joit pai Abormal physical weakess or lack of eergy Although very rare, treatmet with GAMUNEX-C may cause serious side effects such as 15 : Blood clots i the lugs (pulmoary embolism) Have questios about potetial side effects? TALk with a certified urse at Gamuex Coexios. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) 16

17 CIDP SYMPTOM TRACKER To get the most from treatmet with GAMUNEX-C, use this Symptom Tracker to record how the perso you care for is feelig. Ad, make sure he/she shares the fidigs o matter how big or small with his/her eurologist so that treatmet plas ca be adjusted for best results. Please idicate how true each statemet has bee* Not at all = 0 A little bit = 1 A lot = 2 Date of weekly or mothly completio / / / / / / / / I am frustrated by my CIDP I am bothered by pai from CIDP I am off-balace whe walkig because of my CIDP I have trouble gettig dressed because of my CIDP I have trouble sleepig because of my CIDP I am bothered by my limitatios i performig work (icludig work at home) because of my CIDP I have trouble drivig because of my CIDP I am depedet o others because of my CIDP I am depressed about my CIDP I have falle because of my CIDP I am preoccupied because of my CIDP I am uable to do all the leisure activities that I wat to do because of my CIDP I am wor out because of my CIDP I have trouble eatig because of my CIDP I have trouble doig activities aroud the house because of my CIDP Total score *Adapted from Gwathmey KG, et al. 18 To dowload additioal Symptom Tracker forms, go to GAMUNEX-C.com. 17

18 GAMUNEX CONNEXIONS: SINGLE POINT OF CONTACT A dedicated Gamuex Coexios specialist uderstads that the key to uiterrupted treatmet is to have a strog support team behid the perso you care for. Dedicated support durig treatmet with GAMUNEX-C Helps idetify the best available beefits coverage for GAMUNEX-C Provides educatioal iformatio ad resources to address healthcare eeds Support from a certified urse whe eeded Aswers questios about GAMUNEX-C: how it works, what to expect, ad much more Provides iformatio ad support to maage CIDP 18

19 GAMUNEX CONNEXIONS: SAVINGS AND SUPPORT At Gamuex Coexios, our first priority is to provide high-value treatmet ad fiacial support that will help people stay o track with their treatmet pla. Copay assistace is available to eligible patiets Get help with maagig: Deductibles Copaymet Coisurace Fiacial support Through our patiet assistace program, eligible patiets may receive GAMUNEX-C at o cost i the evet of: Loss of isurace Sig up for Gamuex Coexios ad lear how to save up to $2500 over 12 moths. Your dedicated cotact is oly a phoe call away. Call MYGAMUNEX ( ) Moday through Friday (8 am to 8 pm ET) 19

20 15 7 To lear more about GAMUNEX-C ad Gamuex Coexios, visit GAMUNEX-C.com. Please see Importat Safety Iformatio o pages 12 ad 13, ad refer 2018 Grifols All rights reserved April 2018 US/GX/0515/0099(4) To lear more about GAMUNEX-C ad Gamuex Coexios, visit GAMUNEX-C.com. Please see Importat Safety Iformatio o pages 6 ad 7, ad refer 2018 Grifols All rights reserved Jauary 2018 US/GX/0515/0099(4)a THAT S WHY THERE S MORE TO GAMUNEX-C *CIDP=Chroic iflammatory demyeliatig polyeuropathy. Please see Importat Safety Iformatio o pages 12 ad 13, ad refer For trackig my treatmet progress with GAMUNEX-C Get the most out of your treatmet with GAMUNEX-C by followig these simple steps to record ad discuss your symptoms: Prit out this form Complete the survey Share the results with your doctor Use this form oce a week for the first 3 moths of treatmet, ad use it oce a moth after that. Sharig these results ca help your doctor look for ay chages i your CIDP symptoms ad fid the best treatmet regime for you. Please idicate how true each statemet has bee* Not at all = 0 A little bit = 1 A lot = 2 Date of weekly or mothly completio / / / / / / / / I am frustrated by my CIDP I am bothered by pai from CIDP I am off balace whe walkig because of my CIDP I have trouble gettig dressed because of my CIDP I have trouble sleepig because of my CIDP I am bothered by my limitatios i performig work (icludig work at home) because of my CIDP I have trouble drivig because of my CIDP I am depedet o others because of my CIDP I am depressed about my CIDP I have falle because of my CIDP I am preoccupied with my CIDP I am uable to do all the leisure activities that I wat to do because of my CIDP I am wor out because of my CIDP I have trouble eatig because of my CIDP I have trouble doig activities aroud the house Total score *Adapted from Gwathmey KG, et al. 1 Make sure to discuss your resposes ad your total score with your doctor. Please see Importat Safety Iformatio o the reverse side ad refer THAT S WHY THERE S MORE TO GAMUNEX-C *Chroic iflammatory demyeliatig polyeuropathy. Please see Importat Safety Iformatio o pages 6 ad 7, ad refer HELPFUL RESOURCES Educatioal tools These educatioal resources are provided to help you ad the perso you care for lear more about CIDP ad its symptoms, ad to help you have a more iformed coversatio with a eurologist. To access these materials, visit GAMUNEX-C.com. There s more to you YOUR GUIDE TO UNDERSTANDING THE TREATMENT OF CIDP * Uderstadig the Treatmet of CIDP Guide Iformatio o what to expect with CIDP ad iitial treatmet with GAMUNEX-C. Refereces: 1. Chroic iflammatory demyeliatig polyradiculoeuropathy. Uiversity of Rochester Medical Ceter website. Accessed Jauary 9, Chroic iflammatory demyeliatig polyeuropathy (CIDP). Uiversity of Chicago Ceter for Peripheral Neuropathy website. cidp.shtml. Accessed February 16, Gorso KC, Gooch CL. The (mis)diagosis of CIDP: the high price of missig the mark. Neurology. 2015;85(6): Chroic iflammatory demyeliatig polyeuropathy. Natioal Istitutes of Health website. Accessed Jauary 9, Evers E, Hughes R, Rialdi S. CIDP ad the Chroic Variats. Sleaford, UK: Guillai-Barré & Associated Iflammatory Neuropathies (GAIN); Koski CL. CIDP: Chroic Iflammatory Demyeliatig Polyeuropathy. Narberth, PA: GBS/CIDP Foudatio Iteratioal; Köller H, Kieseier BC, Jader S, Hartug HP. Chroic iflammatory demyeliatig polyeuropathy. N Egl J Med. 2005;352(13): Corticosteroid (oral route, pareteral route). Mayo Cliic website. drg ?p=1. Accessed February 24, Steroids. NHS Choices website. corticosteroid-(drugs)/pages/itroductio.aspx. Accessed February 24, Plasmapheresis. Natioal Multiple Sclerosis Society website. Accessed March 10, Treatig lupus with immuosuppressive medicatios. Johs Hopkis Medicie website. hopkislupus.org/lupus-treatmet/lupus-medicatios/immuosuppressive-medicatios/. Accessed February 24, Natioal Istitutes of Health. Uderstadig the Immue System: How It Works. Bethesda, MD: Natioal Istitutes of Health, US Dept of Health ad Huma Services; Data o file, Grifols. 14. GAMUNEX -C (immue globuli ijectio [huma], 10% caprylate/chromatography purified) Prescribig Iformatio. Grifols. 15. Gelfad EW. Differeces betwee IGIV products: impact o cliical outcome. It Immuopharmacol. 2006;6(4): Hughes RAC, Doofrio P, Bril V, et al; o behalf of the ICE Study Group. Itraveous immue globuli (10% caprylate-chromatography purified) for the treatmet of chroic iflammatory demyeliatig polyradiculoeuropathy (ICE study): a radomised placebocotrolled trial. Lacet Neurol. 2008;7(2): My CIDP Symptom Tracker CIDP Symptom Tracker Use this Symptom Tracker to record the results of the perso you care for. Make sure to share with his/her eurologist. There s more to you YOUR GUIDE FOR THE LONG-TERM TREATMENT OF CIDP * Log-term Treatmet of CIDP Guide Iformatio o what to expect as the perso you care for moves further alog i his/her CIDP treatmet jourey. If you have higher tha ormal body fluid volumes or if you have a coditio where icreasig body fluid volume may be a cocer, a higher dose, such as 1g/kg for 1-2 days, is ot recommeded. Because GAMUNEX-C is made from huma blood, it may carry a risk of trasmittig ifectious agets such as viruses, the variat Creutzfeldt-Jakob disease (vcjd) aget, ad, theoretically, the Creutzfeldt-Jakob disease (CJD) aget. You may ot take GAMUNEX-C subcutaeously if you have ITP. If you have ITP ad take GAMUNEX-C subcutaeously, you could experiece a very serious ad life-threateig black ad blue woud (hematoma, which is a pocket of blood withi a tissue). After you take GAMUNEX-C, your blood atibody levels may rise, which could cause some blood atibody tests to give false results. The most commo side effects i a cliical study with PIDD patiets who got subcutaeous ijectios of GAMUNEX-C were ifusio-site reactios such as redess, swellig, ad itchig; extreme tiredess; pai i the regio of the head or eck; a ruy ose, asal cogestio, seezig, cough, ad sputum productio; joit pai; loose stools; a sesatio of uease ad discomfort i the upper stomach; swellig of the tissue liig the siuses; iflammatio of the airways that carry air to your lugs; a feelig of uhappiess, sadess, melacholy, gloom, hopelessess, or low spirits; red rash or bumps, itchy, swolle, ad teder ski with or without blisters or a burig feelig; a severe throbbig pai or a pulsig sesatio, usually o just oe side of the head; muscle pai; familiar ifectious diseases such as the commo cold or flu; ad raised body temperature or fever. I cliical studies with PIDD patiets who got GAMUNEX-C itraveously, the most commo side effects were cough; irritatio ad iflammatio of the mucous membrae iside the ose; sore throat caused by iflammatio of the back of the throat; pai i the regio of the head or eck; a coditio i which your airways arrow ad swell ad produce extra mucus; a sesatio of uease ad discomfort i the upper stomach; raised body temperature or fever; loose stools; ad swellig of the tissue liig the siuses. I a cliical study with CIDP patiets who got GAMUNEX-C itraveously, the most commo side effects were pai i the regio of the head or eck; raised body temperature or fever; abormally high blood pressure; feeligs of coldess accompaied by shiverig; a oticeable chage i the texture or color of your ski such as your ski becomig scaly, bumpy, itchy, or otherwise irritated; a sesatio of uease ad discomfort i the upper stomach; joit pai; ad abormal physical weakess or lack of eergy. I cliical trials with ITP patiets who got GAMUNEX-C itraveously, the most commo side effects were pai i the regio of the head or eck; a discoloratio of the ski resultig from bleedig udereath, typically caused by bruisig; vomitig, fever, ausea, rash, abdomial pai, back pai, ad a pai or a ucomfortable feelig i the upper middle part of your stomach. The most serious side effects i cliical studies were a blood clot to the lug (pulmoary embolism) i 1 patiet with a history of this coditio (i CIDP), a flare-up of a existig type of aemia (autoimmue pure red cell aplasia) i 1 patiet (i PIDD), ad heart iflammatio (myocarditis) i 1 patiet (i ITP). Please see accompayig full Prescribig Iformatio for GAMUNEX-C. You are ecouraged to report egative side effects of prescriptio drugs to the FDA. Visit or call FDA Refereces: 1. Hughes RAC, Doofrio P, Bril V, et al; o behalf of the ICE Study Group. Itraveous immue globuli (10% caprylate-chromatography purified) for the treatmet of chroic iflammatory demyeliatig polyradiculoeuropathy (ICE study): a radomised placebo-cotrolled trial. Lacet Neurol. 2008;7(2): Merkies IS, Bril V, Dalakas MC, et al; o behalf of the ICE Study Group. Health-related quality-of-life improvemets i CIDP with immue globuli IV 10%. Neurology. 2009;72(15): Gamuex Coexios Brochure A overview of the treatmet ad fiacial support resources that are available to the perso you care for. 20

21 CIDP resources ad support The CIDP advocacy orgaizatios below are iteded to coect you ad the perso you care for to additioal educatioal resources about treatmet. GBS-CIDP FOUNDATION INTERNATIONAL* GBS-CIDP Foudatio Iteratioal provides support ad assistace to patiets with Guillai- Barré sydrome (GBS) ad CIDP, ad their families. FOUNDATION FOR PERIPHERAL NEUROPATHY* The Foudatio for Peripheral Neuropathy is the leadig atioal oprofit orgaizatio servig the peripheral europathy commuity. GAMUNEX CONNEXIONS TOOLS & RESOURCES Your source for patiet-focused educatioal materials, tools, ad videos. * Grifols does ot edorse ad is ot resposible for the cotet provided by these resources about treatmet ad patiet-support groups. 21

22 IMPORTANT SAFETY INFORMATION GAMUNEX -C (immue globuli ijectio [huma], 10% caprylate/chromatography purified) is approved to treat primary humoral immuodeficiecy disease (PIDD) i patiets 2 years of age ad older. If you have PIDD, you may take GAMUNEX-C uder the ski (subcutaeously) or i a vei (itraveously). GAMUNEX-C is also approved to treat idiopathic thrombocytopeic purpura (ITP) i adults ad childre ad chroic iflammatory demyeliatig polyeuropathy (CIDP) i adults. If you have ITP or CIDP, you may oly take GAMUNEX-C itraveously. If you take GAMUNEX-C or a similar immue globuli product, you could experiece a serious ad life-threateig blood clot (thromboembolism), which may iclude pai ad/or swellig of a arm or leg with warmth over the affected area, discoloratio of a arm or leg, uexplaied shortess of breath, chest pai or discomfort that worses o deep breathig, uexplaied rapid pulse, umbess, or weakess o oe side of the body. You are more likely to develop a blood clot if you have a history of hardeig of the arteries (atherosclerosis), stroke, heart attack, or heart failure (low volume of blood pumped by the heart). You may also be more likely to get a blood clot if you are elderly, if you have a blood clottig disorder, if you are iactive for log periods of time (such as log bed rest), if you use estroges, or if you have thickeig of your blood. For patiets at risk, GAMUNEX-C should be admiistered at the lowest dose ad slowest ifusio rate that is practical. However, blood clots may occur i the absece of ay of the kow risk factors. Patiets should be well hydrated by drikig eough water before GAMUNEX-C is admiistered. Tell your doctor immediately if your medical history is similar to what is described here, ad especially if you start havig ay of these symptoms while takig GAMUNEX-C. If you take GAMUNEX-C or a similar immue globuli product itraveously, you could experiece serious kidey disease ad death. You may have symptoms of decreased uriatio, sudde weight gai, swellig i your legs (edema), or shortess of breath. You are more likely to develop serious kidey disease if you already have a kidey problem, have Type II diabetes mellitus, or are older tha 65. You are more likely to develop serious kidey disease if you are dehydrated, have a blood ifectio (sepsis), have high protei cotet i your blood, or if you are receivig other medicies that are harmful to your kideys. Tell your doctor immediately if your medical history is similar to what is described here, ad especially if you start havig ay of these symptoms while takig GAMUNEX-C. 22

23 IMPORTANT SAFETY INFORMATION (cot d) You are more likely to develop serious kidey disease if you take a itraveous immue globuli product that cotais sugar (sucrose). GAMUNEX-C does ot cotai sugar. If your situatio makes you more likely to experiece serious kidey disease, you should take GAMUNEX-C at the lowest cocetratio available ad the slowest ifusio rate that is practical. Do ot take GAMUNEX-C if you have a allergy to immue globuli. Tell your doctor if you have had a serious reactio to other medicies that cotai huma immue globuli. Also tell your doctor if you have immuoglobuli A (IgA) deficiecy. If you have a serious reactio while takig GAMUNEX-C, stop takig it immediately ad tell your doctor. Periodic moitorig of kidey fuctio ad urie output is particularly importat i patiets more likely to experiece severe kidey disease. You could experiece other serious ad life-threateig problems due to immue globuli. You could get aseptic meigitis (a type of brai iflammatio with symptoms of severe headache, stiff eck, fatigue, fever, sesitivity to light, paiful eye movemets, ausea, ad vomitig), a blood problem called hemolytic aemia (commo symptoms iclude icreased heart rate, fatigue, yellow ski or eyes, ad dark-colored urie), ad/or a lug problem called trasfusio-related acute lug ijury (commoly referred to as TRALI). TRALI is a coditio where you build up fluid i the lugs (called pulmoary edema) that is ot the result of heart failure. If you have higher tha ormal body fluid volumes or if you have a coditio where icreasig body fluid volume may be a cocer, a higher dose, such as 1g/kg for 1-2 days, is ot recommeded. Because GAMUNEX-C is made from huma blood, it may carry a risk of trasmittig ifectious agets such as viruses, the variat Creutzfeldt-Jakob disease (vcjd) aget, ad, theoretically, the Creutzfeldt-Jakob disease (CJD) aget. You may ot take GAMUNEX-C subcutaeously if you have ITP. If you have ITP ad take GAMUNEX-C subcutaeously, you could experiece a very serious ad life-threateig black ad blue woud (hematoma, which is a pocket of blood withi a tissue). After you take GAMUNEX-C, your blood atibody levels may rise, which could cause some blood atibody tests to give false results. FPO 23

24 IMPORTANT SAFETY INFORMATION (cot d) The most commo side effects i a cliical study with PIDD patiets who got subcutaeous ijectios of GAMUNEX-C were ifusio-site reactios such as redess, swellig, ad itchig; extreme tiredess; pai i the regio of the head or eck; a ruy ose, asal cogestio, seezig, cough, ad sputum productio; joit pai; loose stools; a sesatio of uease ad discomfort i the upper stomach; swellig of the tissue liig the siuses; iflammatio of the airways that carry air to your lugs; a feelig of uhappiess, sadess, melacholy, gloom, hopelessess, or low spirits; red rash or bumps, itchy, swolle, ad teder ski with or without blisters or a burig feelig; a severe throbbig pai or a pulsig sesatio, usually o just oe side of the head; muscle pai; familiar ifectious diseases such as the commo cold or flu; ad raised body temperature or fever. I cliical studies with PIDD patiets who got GAMUNEX-C itraveously, the most commo side effects were cough; irritatio ad iflammatio of the mucous membrae iside the ose; sore throat caused by iflammatio of the back of the throat; pai i the regio of the head or eck; a coditio i which your airways arrow ad swell ad produce extra mucus; a sesatio of uease ad discomfort i the upper stomach; raised body temperature or fever; loose stools; ad swellig of the tissue liig the siuses. I a cliical study with CIDP patiets who got GAMUNEX-C itraveously, the most commo side effects were pai i the regio of the head or eck; raised body temperature or fever; abormally high blood pressure; feeligs of coldess accompaied by shiverig; a oticeable chage i the texture or color of your ski such as your ski becomig scaly, bumpy, itchy, or otherwise irritated; a sesatio of uease ad discomfort i the upper stomach; joit pai; ad abormal physical weakess or lack of eergy. I cliical trials with ITP patiets who got GAMUNEX-C itraveously, the most commo side effects were pai i the regio of the head or eck; a discoloratio of the ski resultig from bleedig udereath, typically caused by bruisig; vomitig, fever, ausea, rash, abdomial pai, back pai, ad a pai or a ucomfortable feelig i the upper middle part of your stomach. The most serious side effects i cliical studies were a blood clot to the lug (pulmoary embolism) i 1 patiet with a history of this coditio (i CIDP), a flare-up of a existig type of aemia (autoimmue pure red cell aplasia) i 1 patiet (i PIDD), ad heart iflammatio (myocarditis) i 1 patiet (i ITP). Please see accompayig full Prescribig Iformatio for GAMUNEX-C. You are ecouraged to report egative side effects of prescriptio drugs to the FDA. Visit or call FDA FPO 24

25 Refereces: 1. Chroic iflammatory demyeliatig polyradiculoeuropathy. Uiversity of Rochester Medical Ceter website. aspx?cotettypeid=134&cotetid=210. Accessed Jauary 9, Chroic iflammatory demyeliatig polyeuropathy. Natioal Istitutes of Health website. article/ htm. Accessed Jauary 9, Köller H, Kieseier BC, Jader S, Hartug HP. Chroic iflammatory demyeliatig polyeuropathy. N Egl J Med. 2005;352(13): Chroic iflammatory demyeliatig polyeuropathy (CIDP). Uiversity of Chicago Ceter for Peripheral Neuropathy website. iflammatory/cidp.shtml. Accessed February 16, Gorso KC, Gooch CL. The (mis)diagosis of CIDP: the high price of missig the mark. Neurology. 2015;85(6): Koski CL. CIDP: Chroic Iflammatory Demyeliatig Polyeuropathy. Narberth, PA: GBS/CIDP Foudatio Iteratioal; Evers E, Hughes R, Rialdi S. CIDP ad the Chroic Variats. Sleaford, UK: Guillai-Barré & Associated Iflammatory Neuropathies (GAIN); Multiple sclerosis: symptoms ad causes. Mayo Cliic website. Accessed February 23, Amyotrophic lateral sclerosis: symptoms ad causes. Mayo Cliic website. dxc ?p=1. Accessed February 23, Amyotrophic lateral sclerosis (ALS) fact sheet. Natioal Istitute of Neurological Disorders ad Stroke website. Patiet-Caregiver-Educatio/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet#Symptoms. Accessed February 23, Guillai-Barré sydrome overview. New York Times. May 21, Accessed February 2, Gorso KC. A update o the maagemet of chroic iflammatory demyeliatig polyeuropathy. Ther Adv Neurol Disord. 2012;5(6): Natioal Istitutes of Health. Uderstadig the Immue System: How It Works. Bethesda, MD: Natioal Istitutes of Health, US Dept of Health ad Huma Services; Data o file, Grifols. 15. GAMUNEX -C (immue globuli ijectio [huma], 10% caprylate/chromatography purified) Prescribig Iformatio. Grifols. 16. Gelfad EW. Differeces betwee IGIV products: impact o cliical outcome. It Immuopharmacol. 2006;6(4): Hughes RAC, Doofrio P, Bril V, et al; o behalf of the ICE Study Group. Itraveous immue globuli (10% caprylate-chromatography purified) for the treatmet of chroic iflammatory demyeliatig polyradiculoeuropathy (ICE study): a radomised placebo-cotrolled trial. Lacet Neurol. 2008;7(2): Gwathmey KG, Coaway MR, Sadjadi R, et al. Costructio ad validatio of the chroic acquired polyeuropathy patiet-reported idex (CAP-PRI): a disease-specific, health-related quality-of-life istrumet. Muscle Nerve. 2016;54(1):

26 To lear more about GAMUNEX-C ad Gamuex Coexios, visit GAMUNEX-C.com. Please see Importat Safety Iformatio o pages 22 to 24, ad refer 2018 Grifols All rights reserved Jue 2018 BN/GXC/1217/0541

There s. more. to you THAT S WHY THERE S MORE TO GAMUNEX-C. *CIDP=Chronic inflammatory demyelinating polyneuropathy.

There s. more. to you THAT S WHY THERE S MORE TO GAMUNEX-C. *CIDP=Chronic inflammatory demyelinating polyneuropathy. There s more to you THAT S WHY THERE S MORE TO GAMUNEX-C YOUR GUIDE TO UNDERSTANDING THE TREATMENT OF CIDP * *CIDP=Chroic iflammatory demyeliatig polyeuropathy. Please see Importat Safety Iformatio o pages

More information

There s. to you THAT S WHY THERE S MORE TO GAMUNEX-C. *Chronic inflammatory demyelinating polyneuropathy.

There s. to you THAT S WHY THERE S MORE TO GAMUNEX-C. *Chronic inflammatory demyelinating polyneuropathy. There s more to you THAT S WHY THERE S MORE TO GAMUNEX-C YOUR GUIDE FOR THE LONG-TERM TREATMENT OF CIDP * *Chronic inflammatory demyelinating polyneuropathy. Please see Important Safety Information on

More information

A PATIENT S GUIDE TO PLASMA EXCHANGE

A PATIENT S GUIDE TO PLASMA EXCHANGE Some drugs may be affected by plasma exchage; ask your doctor about ay impact to drugs you are takig. It is importat to drik water ad cosume foods high i calcium, such as cheese or milk. This ca help your

More information

RADIESSE Dermal Filler for the Correction of Moderate to Severe Facial Wrinkles and Folds, Such As Nasolabial Folds

RADIESSE Dermal Filler for the Correction of Moderate to Severe Facial Wrinkles and Folds, Such As Nasolabial Folds A PATIENT S GUIDE RADIESSE Dermal Filler for the Correctio of Moderate to Severe Facial Wrikles ad Folds, Such As Nasolabial Folds Read all the iformatio before you are treated with Radiesse dermal filler.

More information

Injectable Gel with 0.3% Lidocaine

Injectable Gel with 0.3% Lidocaine Patiet Brochure Table of Cotets Frequetly Asked Questios 4 Safety 6 Troubleshootig 11 Admiistratio 12 Ijectable Gel with.3% Lidocaie Post Marketig Surveillace 13 Post-treatmet Checklist 14 User Assistace

More information

Whether you have a bacterial infection or a viral infection, there are things you can do to help yourself feel better:

Whether you have a bacterial infection or a viral infection, there are things you can do to help yourself feel better: HEALTHPLUS, AN AMERIGROUP COMPANY MakeHealth Happe Vol. 2, 2013 Do I Need Atibiotics? Atibiotics are medicies used to treat bacterial ifectios ad keep them from spreadig. But if a virus makes you sick,

More information

WHAT YOU SHOULD KNOW ABOUT RoACTEMRA

WHAT YOU SHOULD KNOW ABOUT RoACTEMRA RoACTEMRA for Giat Cell Arteritis WHAT YOU SHOULD KNOW ABOUT RoACTEMRA This brochure provides key iformatio to assist i the patiet s uderstadig of the beefits ad risks associated with RoACTEMRA therapy

More information

Information Following Treatment for Patients with Early Breast Cancer. Bradford Teaching Hospitals. NHS Foundation Trust

Information Following Treatment for Patients with Early Breast Cancer. Bradford Teaching Hospitals. NHS Foundation Trust Iformatio Followig Treatmet for Patiets with Early Breast Cacer Bradford Teachig Hospitals NHS Foudatio Trust What happes ext? You have ow completed your iitial treatmet to remove your breast cacer. There

More information

Meningococcal B Prevention Tools for Your Practice

Meningococcal B Prevention Tools for Your Practice Meigococcal B Prevetio Tools for Your Practice NAPNAP MeB Facts for HCPs Fast Facts Although ucommo, MeB is potetially fatal. 1 MeB symptoms progress quickly; death ca occur i 24 hours or less. MeB accouts

More information

Sexuality and chronic kidney disease

Sexuality and chronic kidney disease Sexuality ad chroic kidey disease T H E K I D N E Y F O U N D A T I O N O F C A N A D A 1 Sexuality ad chroic kidey disease Let s talk about it Sexuality is a vital part of us all. It icludes may aspects

More information

Your health matters. Practical tips and sources of support

Your health matters. Practical tips and sources of support Your health matters Practical tips ad sources of support Your health matters Medicie is a challegig ad stressful professio ad doctors are at particular risk of certai health problems as a result. This

More information

GSK Medicine Study Number: Title: Rationale: Study Period: Objectives: Primary Secondary Indication: Study Investigators/Centers: Research Methods

GSK Medicine Study Number: Title: Rationale: Study Period: Objectives: Primary Secondary Indication: Study Investigators/Centers: Research Methods The study listed may iclude approved ad o-approved uses, formulatios or treatmet regimes. The results reported i ay sigle study may ot reflect the overall results obtaied o studies of a product. Before

More information

INFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy

INFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy INFORMATION FOR YOU AND YOUR FAMILY Melody Trascatheter Pulmoary Valve Therapy This booklet is provided to help you ad your loved oes lear more about Melody Trascatheter Pulmoary Valve (TPV) Therapy. Please

More information

YOUR BEST DAYS START WITH BETTER PROTECTION FROM LOWS. *,1,2

YOUR BEST DAYS START WITH BETTER PROTECTION FROM LOWS. *,1,2 YOUR BEST DAYS START WITH BETTER PROTECTION FROM LOWS. *,1,2 Oly SmartGuard TM from MiiMed takes actio for you whe you eed it most. MiiMed 530G system HIT THE ROAD. WORRY LESS ABOUT GOING LOW. *,1,3 37.5%

More information

MEDICAL HOME: Inside: Feeling Blue about the Holidays? Disordered Eating

MEDICAL HOME: Inside: Feeling Blue about the Holidays? Disordered Eating Tee Health Quarter 4, 2011 www.myamerigroup.com/tn MEDICAL HOME: Your First Stop for Health Care Do you have a medical home? It s the first place you should go whe you are sick or hurt. Your medical home

More information

Autism Awareness Education. April 2018

Autism Awareness Education. April 2018 Autism Awareess Educatio April 2018 What is Autism Autism is a wide-spectrum metal disorder that is talked about every day i health circles, but few really kow all the facts about it. Research cotiues

More information

Epilepsy and Family Dynamics

Epilepsy and Family Dynamics Epilepsy ad Family Dyamics BC Epilepsy Society November 15, 2010 Guests: Susa Murphy, Registered Nurse, Paret Rita Marchildo, Child Life Specialist, Paret Speakers: Audrey Ho PhD., R.Psych Josef Zaide

More information

stroke patient handbook

stroke patient handbook OREGON NEUROSCIENCES INSTITUTE Stroke Ceter stroke patiet hadbook To help you ad your family lear about strokes ad stroke care, we have carefully prepared this booklet. It gives you a overview of what

More information

PATIENT INFORMATION BOOKLET. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms

PATIENT INFORMATION BOOKLET. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms PATIENT INFORMATION BOOKLET Edovascular Stet Grafts: A Treatmet for Abdomial Aortic Aeurysms TABLE OF CONTENTS Itroductio 1 Glossary 2 Abdomial Aorta 4 Abdomial Aortic Aeurysm 5 Causes 6 Symptoms 6 Treatmet

More information

1 Barnes D and Lombardo C (2006) A Profile of Older People s Mental Health Services: Report of Service Mapping 2006, Durham University.

1 Barnes D and Lombardo C (2006) A Profile of Older People s Mental Health Services: Report of Service Mapping 2006, Durham University. The Natioal Audit Office udertook a self-assessmet cesus of Commuity Metal Health Teams for Older People (CMHTs) betwee September ad December 2006. The overall fidigs are preseted i the Natioal Audit Office

More information

Skeletal System. Bones Protect. Bones. Bones Store. Bones Move SECTION 2: THE SKELETAL SYSTEM 4/4/16

Skeletal System. Bones Protect. Bones. Bones Store. Bones Move SECTION 2: THE SKELETAL SYSTEM 4/4/16 Skeletal System Skeletal system: the orga system whose primary fuctio is to support ad protect the body ad to allow the body to move SECTION 2: THE SKELETAL SYSTEM Boes The adult huma skeleto has 206 boes.

More information

talking about Men s Health...

talking about Men s Health... Usdaw talkig about Me s Health... Male Cacers This leaflet is desiged to raise me s awareess of the importace of maitaiig their health, particularly whe it comes to cacer. It highlights the two most commo

More information

A guide to immunisations up to 13 months of age

A guide to immunisations up to 13 months of age A guide to immuisatios up to 13 moths of age The complete routie childhood immuisatio programme These booklets describe the immuisatios offered to your child durig the first 18 years of their life. A guide

More information

Certify your stroke care program. Tell your community you re ready when needed.

Certify your stroke care program. Tell your community you re ready when needed. Certify your stroke care program. Tell your commuity you re ready whe eeded. Stroke Certificatio Optios STROKE READY PRIMARY STROKE Stroke Ready Certificatio Demostrates to commuity emergecy services ad

More information

Stacy Norman, D.D.S. William A. Stellenwerf, M.S., D.D.S., P.C Timber Shadows Dr., Bldg. A Kingwood, Texas (281)

Stacy Norman, D.D.S. William A. Stellenwerf, M.S., D.D.S., P.C Timber Shadows Dr., Bldg. A Kingwood, Texas (281) Stac Norma, D.D.S. William A. Stellewerf, M.S., D.D.S., P.C. 2325 Timber Shadows Dr., Bldg. A Kigwood, Texas 77339 (281) 359-9100 PERSONAL HISTORY: Date: Name: Birth Date: Sex: Marital Status: Address:

More information

M e sotheliom a. a UK nursing and inform ation project. Mavis Robinson Project Manager

M e sotheliom a. a UK nursing and inform ation project. Mavis Robinson Project Manager M e sotheliom a a UK ursig ad iform atio project Mavis Robiso Project Maager Mesotheliom a Mesothelioma is a cacer. It most commoly affects the outer liig of the lugs (the pleura). I over 70% of cases

More information

Retention in HIV care among a commercially insured population,

Retention in HIV care among a commercially insured population, Retetio i HIV care amog a commercially isured populatio, 2006-2012 Kathy Byrd, MD, MPH 10th Iteratioal Coferece o HIV Treatmet ad Prevetio Adherece Jue 28 30, 2015 Natioal Ceter for HIV/AIDS, Viral Hepatitis,

More information

Primary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment.

Primary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment. Study No.: AVO112760 Title: A Observatioal Study To Assess The Burde Of Illess I Prostate Cacer Patiets With Low To Moderate Risk Of Progressio Ratioale: Little data are available o the burde of illess

More information

WHAT YOU NEED TO KNOW ABOUT CANCER

WHAT YOU NEED TO KNOW ABOUT CANCER REPUBLIC OF KENYA MINISTRY OF HEALTH WHAT YOU NEED TO KNOW ABOUT CANCER A GUIDE FOR PATIENTS AND CAREGIVERS KENCO Keya Network of Cacer Orgaisatios ACKNOWLEDGEMENT This booklet was prepared by the Keya

More information

APPROVAL REQUIRED. By approving this proof you are confirming that the contact information is correct.

APPROVAL REQUIRED. By approving this proof you are confirming that the contact information is correct. APPROVAL REQUIRED Attached is a proof for your review. Please pay particular attetio to cotact iformatio such as phoe umbers, email addresses, web addresses ad mailig address. By approvig this proof you

More information

Plantar Pressure Difference: Decision Criteria of Motor Relearning Feedback Insole for Hemiplegic Patients

Plantar Pressure Difference: Decision Criteria of Motor Relearning Feedback Insole for Hemiplegic Patients 22 4th Iteratioal Coferece o Bioiformatics ad Biomedical Techology IPCBEE vol.29 (22) (22) IACSIT Press, Sigapore Platar Pressure Differece: Decisio Criteria of Motor Relearig Feedback Isole for Hemiplegic

More information

Psoriatic fatigue: Why do I feel so tired?

Psoriatic fatigue: Why do I feel so tired? PSFT 0518 Psoriatic Fatigue Apr 18.qxp_Layout 1 30/04/2018 15:02 Page 1 Psoriatic fatigue: Why do I feel so tired? A positive approach to psoriasis ad psoriatic arthritis What are the aims of this leaflet?

More information

Hospital Measures. Region 3. Twin Cities Metro: Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, Washington

Hospital Measures. Region 3. Twin Cities Metro: Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, Washington Regio 3 Hospital Measures Twi Cities Metro: Aoka, Carver, Dakota, Heepi, Ramsey, Scott, Washigto 48 Hospital Measures November 2010 2010 Health Care Quality Report Hospital Measures Quality of Care for

More information

Measures of Spread: Standard Deviation

Measures of Spread: Standard Deviation Measures of Spread: Stadard Deviatio So far i our study of umerical measures used to describe data sets, we have focused o the mea ad the media. These measures of ceter tell us the most typical value of

More information

More than skin deep. The medical uses of BOTOX

More than skin deep. The medical uses of BOTOX The medical uses of More tha ski deep Idicatios is a prescriptio medicie that is ijected ito muscles ad used: to treat the abormal head positio ad eck pai that happes with cervical dystoia (CD) i people

More information

Sample. Do not reproduce.

Sample. Do not reproduce. The HealthyLife Maage Your Pai Self-Care Guide helps you idetify ad describe differet types of pai. It presets twety-five methods to treat pai. It also helps you decide whe to maage pai o your ow ad whe

More information

Preparing for Colon or Rectal Surgery

Preparing for Colon or Rectal Surgery Preparig for Colo or Rectal Surgery A successful surgery starts with plaig OUR MISSION As people of Providece, we reveal God s love for all, especially the poor ad vulerable, through our compassioate service.

More information

Ask CancerCare. Questions and Answers on Coping With Cancer. Diane Blum, MSW CancerCare. Jackie Zahora, LCSW-R CancerCare.

Ask CancerCare. Questions and Answers on Coping With Cancer. Diane Blum, MSW CancerCare. Jackie Zahora, LCSW-R CancerCare. ASK CANCERCARE Ask CacerCare Questios ad Aswers o Copig With Cacer Preseted by Diae Blum, MSW CacerCare Jackie Zahora, LCSW-R CacerCare Lear about: Fidig reliable resources Copig with emotios raised by

More information

Chapter 25 Fluid, electrolyte, and acid-base homeostasis

Chapter 25 Fluid, electrolyte, and acid-base homeostasis Chapter 25 Fluid, electrolyte, ad acid-base homeostasis Body Fluid Compartmets I lea adults, body fluids costitute 55% of female ad 60% of male total body mass Itracellular fluid (ICF) iside cells About

More information

Basic Requirements. of meeting cow herd production and profitability goals for the beef cattle enterprise.

Basic Requirements. of meeting cow herd production and profitability goals for the beef cattle enterprise. Basic Requiremets It is imperative that cattle producers have a adequate uderstadig of the basic utriet requiremets of the cow herd to make iformed ad effective utritio-related decisios. by Matt Hersom,

More information

International Journal of Scientific & Engineering Research, Volume 5, Issue 2, February-2014 ISSN

International Journal of Scientific & Engineering Research, Volume 5, Issue 2, February-2014 ISSN ISSN 2229-5518 72 Search For a Biomarker For The Diagosis Ad Progosis of Rheumatoid Arthritis Prasath G, Suil Rao Padmaraj, Vijayakumar T & Riju Mathew Abstract Rheumatoid Arthritis (RA) is oe of the commoest

More information

OPIOID OVERDOSE RELATED EMERGENCY DEPARTMENT VISITS AT PROVIDENCE EVERETT

OPIOID OVERDOSE RELATED EMERGENCY DEPARTMENT VISITS AT PROVIDENCE EVERETT OPIOID OVERDOSE RELATED EMERGENCY DEPARTMENT VISITS AT PROVIDENCE EVERETT Quarterly Report Jue August 2017 Xiyao degrauw Sohomish Health District 3020 Rucker Ave., Everett, WA 98201 Opioid Overdose Related

More information

Dental plans and rates

Dental plans and rates 2016 small busiess CALIFORNIA Detal plas ad rates For effective dates Jauary 1 December 1, 2016 Coachella Valley Kaiser Permaete Isurace Compay (KPIC) Coachella Valley 4 For effective dates Jauary 1 December

More information

Statistical Analysis and Graphing

Statistical Analysis and Graphing BIOL 202 LAB 4 Statistical Aalysis ad Graphig Aalyzig data objectively to determie if sets of data differ ad the to preset data to a audiece succictly ad clearly is a major focus of sciece. We eed a way

More information

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner.

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner. Restylae Lyft with Lidocaie Ijectable Gel with.% Lidocaie Cautio: Federal Law restricts this device to sale by or o the order of a physicia or licesed practitioer. Descriptio Restylae Lyft with Lidocaie

More information

Hospital Measures. Region 2

Hospital Measures. Region 2 Regio 2 Hospital Measures Northeast ad Cetral: Aitki, Beto, Carlto, Cass, Chisago, Cook, Crow Wig, Isati, Itasca, Kaabec, Koochichig, Lake, Mille Lacs, Morriso, Pie, Sherbure, St. Louis, Stears, Todd,

More information

Pilot and Exploratory Project Support Grant

Pilot and Exploratory Project Support Grant KEY DATES LETTERS OF INTENT DUE November 3, 2014 5:00 pm est FULL PROPOSAL INVITATIONS November 17, 2014 FULL PROPOSAL DEADLINE Jauary 15, 2015 5:00 pm est NOTIFICATION OF AWARDS April, 2015 Pilot ad Exploratory

More information

Dental plans and rates

Dental plans and rates 2016 small busiess CALIFORNIA Detal plas ad rates For effective dates Jauary 1 December 1, 2016 Ker Couty Kaiser Permaete Isurace Compay (KPIC) Ker Couty For effective dates Jauary 1 December 1, 2016 Premier

More information

Hospital Measures. Region 1

Hospital Measures. Region 1 Regio 1 Hospital Measures Northwest ad West Cetral: Becker, Beltrami, Clay, Clearwater, Douglas, Grat, Hubbard, Kittso, Lake of the Woods, Mahome, Marshall, Norma, Otter Tail, Peigto, Polk, Pope, Red Lake,

More information

Click to Edit Master Title

Click to Edit Master Title Click to Edit Master Title Persoalized Pai Recovery for City & Couty of Sa Fracisco Employees & Retirees March 9, 2017 Click to Edit Master Title Retirees Police Teachers DPW Desk Fire Fighters PUC MTA

More information

Years 3-4. Information. Introduction. Key understandings

Years 3-4. Information. Introduction. Key understandings Iformatio Updated Jue 2016 Itroductio These activities provide the kowledge ad uderstadig ad embedded skill developmet that foster allergy awareess ad safety amog Year studets. These uderstadigs ad skills

More information

Review for Chapter 9

Review for Chapter 9 Review for Chapter 9 1. For which of the followig ca you use a ormal approximatio? a) = 100, p =.02 b) = 60, p =.4 c) = 20, p =.6 d) = 15, p = 2/3 e) = 10, p =.7 2. What is the probability of a sample

More information

STATISTICAL ANALYSIS & ASTHMATIC PATIENTS IN SULAIMANIYAH GOVERNORATE IN THE TUBER-CLOSES CENTER

STATISTICAL ANALYSIS & ASTHMATIC PATIENTS IN SULAIMANIYAH GOVERNORATE IN THE TUBER-CLOSES CENTER March 3. Vol., No. ISSN 37-3 IJRSS & K.A.J. All rights reserved STATISTICAL ANALYSIS & ASTHMATIC PATIENTS IN SULAIMANIYAH GOVERNORATE IN THE TUBER-CLOSES CENTER Dr. Mohammad M. Faqe Hussai (), Asst. Lecturer

More information

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner.

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner. Restylae Lyft with Lidocaie Ijectable Gel with.3% Lidocaie Cautio: Federal Law restricts this device to sale by or o the order of a physicia or licesed practitioer. Descriptio Restylae Lyft with Lidocaie

More information

How a Written Back-Up Plan Saves Money and Lives. Jill Emerick, MD

How a Written Back-Up Plan Saves Money and Lives. Jill Emerick, MD DKA, Quality, ad Costs: How a Writte Back-Up Pla Saves Moey ad Lives Traci Carter, MA, RN, CDE Aa Isfort, MD Kare Vogt, MD Jill Emerick, MD 18 // AADE I Practice // March 2017 Early last summer, we, the

More information

Statistics 11 Lecture 18 Sampling Distributions (Chapter 6-2, 6-3) 1. Definitions again

Statistics 11 Lecture 18 Sampling Distributions (Chapter 6-2, 6-3) 1. Definitions again Statistics Lecture 8 Samplig Distributios (Chapter 6-, 6-3). Defiitios agai Review the defiitios of POPULATION, SAMPLE, PARAMETER ad STATISTIC. STATISTICAL INFERENCE: a situatio where the populatio parameters

More information

Years K-2. Information. Introduction. Key understandings

Years K-2. Information. Introduction. Key understandings Iformatio Updated Jue 2016 Itroductio These activities provide the kowledge ad uderstadig ad embedded skill developmet that foster allergy awareess ad safety amog Foudatio-Year 2 studets. These uderstadigs

More information

Guide to common medical conditions

Guide to common medical conditions Guide to commo medical coditios Helpig you uderstad our uderwritig approach to the most commoly disclosed medical coditios Cacer Hypertesio Kidey stoes Metal health Sleep Apoea AMP Life Limited ABN 84

More information

SCULPTRA Aesthetic (First Treatment Session: N = 116) Cosmoplast (First Treatment Session: N = 117) Severity of Adverse Event a Moderate n.

SCULPTRA Aesthetic (First Treatment Session: N = 116) Cosmoplast (First Treatment Session: N = 117) Severity of Adverse Event a Moderate n. SCULPTRA AESTHETIC Rx Oly (ijectable poly-l-lactic acid) The Sculptra implat package (i.e., lyophilized vials ad syrige) are provided sterile. Cautio: Federal (USA) law restricts this device to sale by

More information

Dental plans and rates

Dental plans and rates 208 small busiess CALIFORNIA Detal plas ad rates For effective dates Jauary December, 208 Souther Califoria Souther Califoria Kaiser Permaete Isurace Compay (KPIC) For effective dates Jauary December,

More information

Dental plans and rates

Dental plans and rates For More ifo...http://www.steveshorr.com/ab_1672_small_group_guarateed_issue/detal_employer_group.htm 2013 small busiess Califoria Detal plas ad rates For effective dates Jauary 1 Jue 1, 2013 Souther Califoria

More information

Should We Care How Long to Publish? Investigating the Correlation between Publishing Delay and Journal Impact Factor 1

Should We Care How Long to Publish? Investigating the Correlation between Publishing Delay and Journal Impact Factor 1 Should We Care How Log to Publish? Ivestigatig the Correlatio betwee Publishig Delay ad Joural Impact Factor 1 Jie Xu 1, Jiayu Wag 1, Yuaxiag Zeg 2 1 School of Iformatio Maagemet, Wuha Uiversity, Hubei,

More information

Sampling Distributions and Confidence Intervals

Sampling Distributions and Confidence Intervals 1 6 Samplig Distributios ad Cofidece Itervals Iferetial statistics to make coclusios about a large set of data called the populatio, based o a subset of the data, called the sample. 6.1 Samplig Distributios

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team.

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team. Research Team Early Ambulatio Reduces the Risk of Veous Thromboembolism After Total Kee Replacemet Marily Szekedi, PhD, RN Baafsheh Sadeghi, MD, PhD, School of Medicie, Uiversity of Califoria Davis Patrick

More information

Statistics Lecture 13 Sampling Distributions (Chapter 18) fe1. Definitions again

Statistics Lecture 13 Sampling Distributions (Chapter 18) fe1. Definitions again fe1. Defiitios agai Review the defiitios of POPULATIO, SAMPLE, PARAMETER ad STATISTIC. STATISTICAL IFERECE: a situatio where the populatio parameters are ukow, ad we draw coclusios from sample outcomes

More information

Simple intervention to improve detection of hepatitis B and hepatitis C in general practice

Simple intervention to improve detection of hepatitis B and hepatitis C in general practice Simple itervetio to improve detectio of hepatitis B ad hepatitis C i geeral practice Zayab al-lami (GP-Birmigham) Co-authors:-Sarah Powell, Sally Bradshaw, Amada Lambert, David Mutimer ad Adrew Rouse Presetatio

More information

Modified Early Warning Score Effect in the ICU Patient Population

Modified Early Warning Score Effect in the ICU Patient Population Lehigh Valley Health Network LVHN Scholarly Works Patiet Care Services / Nursig Modified Early Warig Score Effect i the ICU Patiet Populatio Ae Rabert RN, DHA, CCRN, NE-BC Lehigh Valley Health Network,

More information

Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus

Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus Cliical evidece of the role of belimumab i the treatmet of systemic lupus erythematosus Cli. Ivest. (2011) 1(11), 1555 1561 Belimumab is a huma moocloal atibody that bids soluble B lymphocyte stimulator,

More information

The Human Body. Introduction. Human body. Nervous system Musculoskeletal system. Cardiovascular system. Produces movements.

The Human Body. Introduction. Human body. Nervous system Musculoskeletal system. Cardiovascular system. Produces movements. Itroductio Huma body Nervous system Musculoskeletal system Muscular forces Muscle extesio ad cotractio Complex system of muscles ad boes Produces movemets Cardiovascular system Heart Blood vessels Respiratory

More information

Pilot and Exploratory Project Support Grant

Pilot and Exploratory Project Support Grant KEY DATES LETTERS OF INTENT DUE November 2, 2015 5:00 pm est FULL PROPOSAL INVITATIONS November 16, 2015 FULL PROPOSAL DEADLINE Jauary 15, 2016 5:00 pm est NOTIFICATION OF AWARDS April, 2016 Pilot ad Exploratory

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: UM27/189/ The study listed may iclude approved ad o-approved uses, formulatios or treatmet regimes. The results reported i ay sigle study may ot reflect the overall results obtaied o studies of a product.

More information

Exercise & Aging: The Fountain of Age

Exercise & Aging: The Fountain of Age Exercise & Agig: The Foutai of Age Ke Brummel-Smith, MD Charlotte Edwards Maguire Professor & Chair, Departmet of Geriatrics FSU College of Medicie Objectives Discuss the risks of a sedetary life Discuss

More information

Winning the Battle Within

Winning the Battle Within Complimets of Johs Hopkis Medicie Iteratioal fall 2013 Wiig the Battle Withi Isight ad ews from Johs Hopkis Medicie Iovatios are chagig what we kow about autoimmue diseases ad, ultimately, how to stop

More information

Eastern Hog-nosed Snake

Eastern Hog-nosed Snake Miistry of Natural Resources Easter Hog-osed Sake Otario Govermet Respose Statemet Photo: Alle Woodliffe PROTECTING AND RECOVERING SPECIES AT RISK IN ONTARIO Species at risk recovery is a key part of protectig

More information

The Skeletal System: Bone Tissue Chapter 6. Copyright 2009, John Wiley & Sons, Inc.

The Skeletal System: Bone Tissue Chapter 6. Copyright 2009, John Wiley & Sons, Inc. The Skeletal System: Boe Tissue Chapter 6 Fuctios of Boe ad Skeletal System Support Protectio Assistace i Movemet Mieral Homeostasis Blood Cell Productio(Hemopoiesis) q Triglyceride Storage q Yellow boe

More information

Disclosure. Update in Pediatric Asthma 7/5/16. Topics. California Society for Respiratory Care Indian Wells, CA June 7, 2016

Disclosure. Update in Pediatric Asthma 7/5/16. Topics. California Society for Respiratory Care Indian Wells, CA June 7, 2016 Update i Pediatric Asthma Califoria Society for Respiratory Care Idia Wells, CA Jue 7, 2016 Sade Okelo, MD, PhD The David Geffe School of Medicie at UCLA Mattel Childre s Hospital Divisio of Pediatric

More information

Living with Osteoarthritis

Living with Osteoarthritis Arthritis Irelad 1 Clawilliam Square Grad Caal Quay Dubli 2 Helplie LoCall 1890 252 846 Email ifo@arthritisirelad.ie Web www.arthritisirelad.ie Livig with Osteoarthritis PERSONAL DETAILS Arthritis Irelad,

More information

Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin)

Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) Sigle ad multidose pharmacokietic study of a vagial microized progesteroe isert (Edometri) 按一下以編輯母片副標題樣式 compared with vagial gel i healthy reproductive-aged E m ily J. B la ke, M.D., Fertility a d S terility

More information

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION JUST FOR KIDS For children ages 6-17 with moderately to severely active Crohn s disease or ulcerative colitis (UC) who haven t responded well to other therapies SELECTED IMPORTANT SAFETY INFORMATION REMICADE

More information

Objectives. Sampling Distributions. Overview. Learning Objectives. Statistical Inference. Distribution of Sample Mean. Central Limit Theorem

Objectives. Sampling Distributions. Overview. Learning Objectives. Statistical Inference. Distribution of Sample Mean. Central Limit Theorem Objectives Samplig Distributios Cetral Limit Theorem Ivestigate the variability i sample statistics from sample to sample Fid measures of cetral tedecy for distributio of sample statistics Fid measures

More information

Health and Wellbeing. Tackling health inequalities through learning in the West Midlands.

Health and Wellbeing. Tackling health inequalities through learning in the West Midlands. Health ad Wellbeig Tacklig health iequalities through learig i the West Midlads http://www.westmidlads.wea.org.uk/ Health ad wellbeig What WEA West Midlads ca offer We are a adult educatio provider that

More information

DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES*

DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES* FERTILITY AND STERILITY Copyright 1972 by The Williams & Wilkis Co. Vol. 23, No.4, April 1972 Prited i U.S.A. DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES* R. ELIASSON,

More information

EMPOWERING THE RARE DISEASE COMMUNITY CONNECT VOICE RESEARCH INNOVATE

EMPOWERING THE RARE DISEASE COMMUNITY CONNECT VOICE RESEARCH INNOVATE EMPOWERING THE RARE DISEASE COMMUNITY CONNECT VOICE RESEARCH INNOVATE OCTOBER 2012 A report to our costituets NORD is the recogized atioal leader drivig progress o behalf of the etire rare disease commuity.

More information

Prepare to unleash your inner elf

Prepare to unleash your inner elf Prepare to uleash your ier elf It s fu. It s festive. Ad it s for a fatastic cause. Yes, 8 December is Elf Day, whe people across the atio uite i support of people affected by demetia. Hostig a Elf Day

More information

Primary Care. The comprehensive approach to overall health. The sleep and depression connection. One doctor s crusade against sudden cardiac death

Primary Care. The comprehensive approach to overall health. The sleep and depression connection. One doctor s crusade against sudden cardiac death Complimets of Johs Hopkis Medicie Iteratioal Summer 2012 Isight ad ews from Johs Hopkis Medicie Primary Care The comprehesive approach to overall health The sleep ad depressio coectio Oe doctor s crusade

More information

Systemic and Novel Management of Alopecia Areata in Children. Alopecia Areata: Prognosis. Alopecia Areata. Alopecia Areata: Pathogenesis

Systemic and Novel Management of Alopecia Areata in Children. Alopecia Areata: Prognosis. Alopecia Areata. Alopecia Areata: Pathogenesis Systemic ad Novel Maagemet of Alopecia Areata i Childre Kimberly Morel, MD, FAAD, FAAP Associate Professor of Dermatology & Pediatrics S006 - Treatig Severe Ski Disease i Childre 02/16/2018, 9:00 AM Room

More information

CHAPTER NINE: MITOSIS NOTES PT. 3

CHAPTER NINE: MITOSIS NOTES PT. 3 CHAPTER NINE: MITOSIS NOTES PT. 3 The Cellular Basis of Iheritace What Happes Whe Mitosis Goes Wrog?? Cacer Caused by ucotrolled cell reproductio (mitosis) ad severe disruptio of the mechaisms that cotrol

More information

Teacher Manual Module 3: Let s eat healthy

Teacher Manual Module 3: Let s eat healthy Teacher Maual Module 3: Let s eat healthy Teacher Name: Welcome to FLASH (Fu Learig Activities for Studet Health) Module 3. I the Uited States, more studets are developig type 2 diabetes tha ever before.

More information

Stroke in the emergency department

Stroke in the emergency department Cambridge Uiversity Press 978-0-521-67494-2 - Acute Stroke Care: A Maual from the Uiversity of Texas-Housto Stroke Team Ke Uchio, Jeifer K. Pary ad James C. Grotta More iformatio 1 Stroke i the emergecy

More information

Mechanism of Action: The Importance of Liver THR-β in NASH

Mechanism of Action: The Importance of Liver THR-β in NASH MGL-3196, a selective thyroid hormoe receptor-beta agoist, sigificatly decreases hepatic fat i NASH patiets at 12 weeks, the primary edpoit i a 36 week serial liver biopsy study Stephe Harriso 1, Sam Moussa

More information

MEMO. COMMISSION AGENDA: /l!1./y- 1f.Jtf. Members, Pinellas County Commission FROM: Karen Williams Seel, Chair Pinellas County Commission CC:

MEMO. COMMISSION AGENDA: /l!1./y- 1f.Jtf. Members, Pinellas County Commission FROM: Karen Williams Seel, Chair Pinellas County Commission CC: MEMO COMMSSON AGENDA: /l!1./y- 1f.Jtf ' TO: Members, Piellas Couty Commissio FROM: Kare Williams Seel, Chair Piellas Couty Commissio CC: Mark Woodard, Couty Admiistrator Jim Beett, Couty Attorey RE: Voluteer

More information

5/7/2014. Standard Error. The Sampling Distribution of the Sample Mean. Example: How Much Do Mean Sales Vary From Week to Week?

5/7/2014. Standard Error. The Sampling Distribution of the Sample Mean. Example: How Much Do Mean Sales Vary From Week to Week? Samplig Distributio Meas Lear. To aalyze how likely it is that sample results will be close to populatio values How probability provides the basis for makig statistical ifereces The Samplig Distributio

More information

Chapter 8 Descriptive Statistics

Chapter 8 Descriptive Statistics 8.1 Uivariate aalysis ivolves a sigle variable, for examples, the weight of all the studets i your class. Comparig two thigs, like height ad weight, is bivariate aalysis. (Which we will look at later)

More information

The Time Is Now! Be active and fit. Be ready to take. the President s Challenge! Physical Activity, Nutrition & Fitness. The President s Challenge

The Time Is Now! Be active and fit. Be ready to take. the President s Challenge! Physical Activity, Nutrition & Fitness. The President s Challenge The Presidet s Challege Physical Activity, Nutritio & Fitess Awards Program Get Fit The Time Is Now! Be active ad fit. Be ready to take the Presidet s Challege! A Program of the Presidet s Coucil o Fitess,

More information

Comments Table with Responses from Developers

Comments Table with Responses from Developers Natioal Istitute for Health ad Cliical Excellece ADHD Cosultatio 31 st Jauary 27 th March 2008 Commets Table with Resposes from Developers Status = Registered Stakeholders PR = Ivited Expert Peer Reviewers

More information

Practical Basics of Statistical Analysis

Practical Basics of Statistical Analysis Practical Basics of Statistical Aalysis David Keffer Dept. of Materials Sciece & Egieerig The Uiversity of Teessee Koxville, TN 37996-2100 dkeffer@utk.edu http://clausius.egr.utk.edu/ Goveror s School

More information

7th World Congress of Veterinary Dermatology

7th World Congress of Veterinary Dermatology Focus o the Sciece UPDATE: 7th World Cogress of Veteriary Dermatology VANCOUVER JULY 2012 WWW.ITCHCYCLE.COM NEW INSIGHTS AND SCIENTIFIC FINDINGS THE WORLD CONGRESS OF VETERINARY DERMATOLOGY orgaized uder

More information

Ch 9 In-class Notes: Cell Reproduction

Ch 9 In-class Notes: Cell Reproduction Ch 9 I-class Notes: Cell Reproductio All cells grow, duplicate their DNA, ad divide to multiply. This is called the cell cycle. Most Prokaryotic cells divide via biary fissio. Most Eukaryotic cells divide

More information

SPONDYLODISCITIS KEY POINTS

SPONDYLODISCITIS KEY POINTS KEY POINTS SEPPO KOSKINEN, M.D., Ph.D. Professor Divisio of Radiology Departmet of Cliical Sciece, Itervetio ad Techology (CLINTEC) Seior Cosultat Fuctio Imagig & Physiology Fuctioal Area for Trauma ad

More information